GI
CLMT icon

GAMMA Investing’s Calumet Specialty Products CLMT Stock Holding History

GAMMA Investing’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.5K Buy
926
+359
+63% +$17K ﹤0.01% 2382
2026
Q2 		$20.4K Buy
567
+26
+5% +$874 ﹤0.01% 2826
2026
Q1 		$19.4K Buy
541
+168
+45% +$4.35K ﹤0.01% 2726
2025
Q4 		$7.41K Buy
373
+126
+51% +$2.42K ﹤0.01% 3113
2025
Q3 		$4.51K Buy
247
+145
+142% +$2.38K ﹤0.01% 3215
2025
Q2 		$1.61K Hold
102
– – ﹤0.01% 3444
2025
Q1 		$1.29K Buy
+102
New +$1.6K ﹤0.01% 3508

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
OKSA
O'Keefe Stevens Advisory Rochester, New York $489M AUM 37.59% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's CLMT Position: Q3 2026 in Review

GAMMA Investing increased its Calumet Specialty Products (CLMT) stake by 63% in Q3 2026, buying an estimated $17K and bringing the position to 926 shares worth $48.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

GAMMA Investing first reported a position in CLMT in Q1 2025 and has held it in 7 quarters since. 7 funds tracked by Wall St. Rank hold CLMT as of Q3 2026.

  • GAMMA Investing held 926 shares of Calumet Specialty Products worth $48.5K as of Q3 2026.
  • GAMMA Investing bought 359 Calumet Specialty Products shares in Q3 2026, an estimated $17K.
  • Calumet Specialty Products made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2382 holding.
  • GAMMA Investing first reported a position in Calumet Specialty Products in Q1 2025 and has held it in 7 quarters since.
  • 7 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.